Pear Therapeutics and Prescryptive Health announce formulary coverage for prescription digital therapeutics reSET & reSET-O for the treatment of substance and opioid use disorders

Pear Therapeutics

1 April 2021 - Prescryptive Health, a health intelligence platform focused on improving the prescription drug market and the pharmacy experience, teams with Pear to make innovative prescription digital therapeutics accessible to its members in recovery.

Pear Therapeutics and Prescryptive Health today announced that Prescryptive, the first health intelligence platform, will offer and administer benefit coverage for reSET and reSET-O, the first two prescription digital therapeutics to receive authorisation from the U.S. FDA to treat disease. 

reSET and reSET-O have been added to Prescryptive’s formularies and are being administered as standard pharmacy benefits for its members.

Read Pear Therapeutics press release

Michael Wonder

Posted by:

Michael Wonder